Potential mechanisms of neurogenic tumor maturation
- Authors: Zverev I.A.1,2, Druy A.E.2,3
-
Affiliations:
- The N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation
- The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
- Research Institute of Medical Cell Technologies
- Issue: Vol 23, No 3 (2024)
- Pages: 176-197
- Section: LITERATURE REVIEW
- Submitted: 16.10.2024
- Accepted: 16.10.2024
- Published: 08.07.2025
- URL: https://hemoncim.com/jour/article/view/905
- DOI: https://doi.org/10.24287/1726-1708-2024-23-3-176-197
- ID: 905
Cite item
Full Text
Abstract
In the past years, a significant progress has been achieved in the development of techniques to study morphology and molecular processes within tissues, single cells, and even subcellular structures. This has led to qualitatively new insights into the causes of certain previously unexplained clinical phenomena in oncology, including the rare and paradoxical ability of malignant tumors to become benign. In this review, we critically analyze the existing hypotheses regarding the mechanisms underlying neurogenic tumor maturation, taking into consideration recent data on their origins and biological properties. We also evaluate the potential implications of this knowledge for clinical practice.
About the authors
I. A. Zverev
The N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation; The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Moscow
Russian FederationA. E. Druy
The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation; Research Institute of Medical Cell Technologies
Author for correspondence.
Email: dr-drui@yandex.ru
ORCID iD: 0000-0003-1308-8622
Alexander E. Druy - Cand. Med. Sci., Head of the Laboratory of Molecular Oncology.
1 Samory Mashela St., Moscow 117997
Russian FederationReferences
Supplementary files
